Icagen Reviews

4.0
Recommend to a friend
Approve of CEO
(no image)
P. Kay Wagoner
1 Rating
  • Energetic small biotech

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Scientist in Durham, NC
    Former Employee - Scientist in Durham, NC

    I worked at Icagen full-time (More than 3 years)

    Recommends
    Neutral Outlook
    Approves of CEO
    Recommends
    Neutral Outlook
    Approves of CEO

    Pros

    Great people and a can do attitude. Was fun to progress compounds that could make it to the clinic and serve patients

    Cons

    Because of small size opportunity for advancement was limited. Management was very micro-managing and not very trusting of the expertise of the staff they hired.

    Advice to Management

    Culture would have benefited from being less micro-managerial


Icagen Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.icagen.com
Headquarters Durham, NC
Size 16 to 50 Employees
Founded Unknown
Type Company - Private
Industry Biotech & Pharmaceuticals
Revenue $10 to $25 million (USD) per year

Icagen wants to set the market for ion channel modulators on fire. The development-stage biotech focuses on treatments for epilepsy, asthma, pain, and inflammation by regulating the inflow into cells of such ions as calcium, potassium, and sodium. Icagen's lead candidate, senicapoc for sickle cell disease, died in 2007 following lackluster Phase III clinical trial results. The drug was being developed in a partnership with Johnson & Johnson subsidiary McNeil Consumer & Specialty Pharmaceuticals. Shortly thereafter Icagen announced a deal collaborating with ... More

Work at Icagen? Share Your Experiences

Icagen

 
Click to Rate
or